These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6538482)

  • 1. Inactive proenzyme to tissue-type plasminogen activator from human melanoma cells, identified after affinity purification with a monoclonal antibody.
    Andreasen PA; Nielsen LS; Grøndahl-Hansen J; Skriver L; Zeuthen J; Stephens RW; Danø K
    EMBO J; 1984 Jan; 3(1):51-6. PubMed ID: 6538482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody.
    Nielsen LS; Hansen JG; Skriver L; Wilson EL; Kaltoft K; Zeuthen J; Danø K
    Biochemistry; 1982 Dec; 21(25):6410-5. PubMed ID: 6891264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody to human 66,000 molecular weight plasminogen activator from melanoma cells. Specific enzyme inhibition and one-step affinity purification.
    Nielsen LS; Hansen JG; Andreasen PA; Skriver L; Danø K; Zeuthen J
    EMBO J; 1983; 2(1):115-9. PubMed ID: 11894897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator released as inactive proenzyme from murine cells transformed by sarcoma virus.
    Skriver L; Nielsen LS; Stephens R; Danø K
    Eur J Biochem; 1982 May; 124(2):409-14. PubMed ID: 6284507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins.
    Toki N; Sumi H; Sasaki K; Boreisha I; Robbins KC
    J Clin Invest; 1985 Apr; 75(4):1212-22. PubMed ID: 3921568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteolytic cleavage of single-chain pro-urokinase induces conformational change which follows activation of the zymogen and reduction of its high affinity for fibrin.
    Kasai S; Arimura H; Nishida M; Suyama T
    J Biol Chem; 1985 Oct; 260(22):12377-81. PubMed ID: 3930494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal regulation of extracellular plasminogen activators and Mr approximately 54,000 plasminogen activator inhibitor in human neoplastic cell lines, studied with monoclonal antibodies.
    Andreasen PA; Christensen TH; Huang JY; Nielsen LS; Wilson EL; Danø K
    Mol Cell Endocrinol; 1986 May; 45(2-3):137-47. PubMed ID: 3011558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activators catalyse conversion of inhibitor from fibrosarcoma cells to an inactive form with a lower apparent molecular mass.
    Nielsen LS; Andreasen PA; Grøndahl-Hansen J; Skriver L; Danø K
    FEBS Lett; 1986 Feb; 196(2):269-73. PubMed ID: 3081367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies inhibitory to human plasmin. Definitive demonstration of a role for plasmin in activating the proenzyme of urokinase-type plasminogen activator.
    Sim PS; Fayle DR; Doe WF; Stephens RW
    Eur J Biochem; 1986 Aug; 158(3):537-42. PubMed ID: 2942403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A monoclonal antibody specific for two-chain urokinase-type plasminogen activator. Application to the study of the mechanism of clot lysis with single-chain urokinase-type plasminogen activator in plasma.
    Declerck PJ; Lijnen HR; Verstreken M; Moreau H; Collen D
    Blood; 1990 May; 75(9):1794-800. PubMed ID: 1691934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolytic properties of an inactive proenzyme form of human urokinase secreted from human kidney cells.
    Kasai S; Arimura H; Nishida M; Suyama T
    Cell Struct Funct; 1985 Jun; 10(2):151-9. PubMed ID: 3924420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and properties of a plasminogen activator from cultured rat prostate adenocarcinoma cells.
    Strickland DK; de Serrano VS; Chan SY; Pollard M; Castellino FJ
    Biochemistry; 1983 Sep; 22(19):4444-9. PubMed ID: 6684952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional characterization of mutants of recombinant single-chain urokinase-type plasminogen activator obtained by site-specific mutagenesis of Lys158, Ile159 and Ile160.
    Lijnen HR; Nelles L; Van Hoef B; Demarsin E; Collen D
    Eur J Biochem; 1988 Nov; 177(3):575-82. PubMed ID: 2973984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of a melanoma cell plasminogen activator.
    Wallén P; Pohl G; Bergsdorf N; Rånby M; Ny T; Jörnvall H
    Eur J Biochem; 1983 May; 132(3):681-6. PubMed ID: 6682760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of human fibroblast urokinase proenzyme and analysis of its regulation by proteases and protease nexin.
    Eaton DL; Scott RW; Baker JB
    J Biol Chem; 1984 May; 259(10):6241-7. PubMed ID: 6373753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fish plasminogen activators: their identification and characterization.
    Takahashi K; Wakamatsu Y; Ozato K; Wakayama Y
    Cell Struct Funct; 1987 Feb; 12(1):11-22. PubMed ID: 3552260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.
    Stephens RW; Pöllänen J; Tapiovaara H; Leung KC; Sim PS; Salonen EM; Rønne E; Behrendt N; Danø K; Vaheri A
    J Cell Biol; 1989 May; 108(5):1987-95. PubMed ID: 2523891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture.
    Rijken DC; Collen D
    J Biol Chem; 1981 Jul; 256(13):7035-41. PubMed ID: 6787058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies to human 54,000 molecular weight plasminogen activator inhibitor from fibrosarcoma cells--inhibitor neutralization and one-step affinity purification.
    Nielsen LS; Andreasen PA; Grøndahl-Hansen J; Huang JY; Kristensen P; Danø K
    Thromb Haemost; 1986 Apr; 55(2):206-12. PubMed ID: 3520936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrin binding and zymogenic properties of single-chain urokinase (pro-urokinase).
    Gurewich V; Pannell R
    Semin Thromb Hemost; 1987 Apr; 13(2):146-51. PubMed ID: 3114882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.